CME Group Inc. $CME Holdings Trimmed by APG Asset Management N.V.

APG Asset Management N.V. reduced its position in shares of CME Group Inc. (NASDAQ:CME) by 1.4% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 261,065 shares of the financial services provider’s stock after selling 3,651 shares during the quarter. APG Asset Management N.V. owned 0.07% of CME Group worth $70,537,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also modified their holdings of the company. Amundi grew its holdings in shares of CME Group by 24.0% during the 2nd quarter. Amundi now owns 1,987,347 shares of the financial services provider’s stock valued at $548,150,000 after acquiring an additional 385,225 shares in the last quarter. Truist Financial Corp raised its holdings in shares of CME Group by 8.9% during the third quarter. Truist Financial Corp now owns 70,712 shares of the financial services provider’s stock worth $19,106,000 after acquiring an additional 5,773 shares in the last quarter. Alley Investment Management Company LLC boosted its position in CME Group by 86.0% during the third quarter. Alley Investment Management Company LLC now owns 29,223 shares of the financial services provider’s stock valued at $7,896,000 after purchasing an additional 13,512 shares during the last quarter. Elevate Capital Advisors LLC grew its stake in CME Group by 85.2% in the third quarter. Elevate Capital Advisors LLC now owns 8,519 shares of the financial services provider’s stock valued at $2,302,000 after purchasing an additional 3,919 shares in the last quarter. Finally, Victory Financial Group LLC grew its stake in CME Group by 310.2% in the second quarter. Victory Financial Group LLC now owns 3,044 shares of the financial services provider’s stock valued at $839,000 after purchasing an additional 2,302 shares in the last quarter. Institutional investors and hedge funds own 87.75% of the company’s stock.

Insider Activity

In other CME Group news, CEO Terrence A. Duffy sold 25,000 shares of the company’s stock in a transaction that occurred on Thursday, December 11th. The stock was sold at an average price of $269.55, for a total value of $6,738,750.00. Following the completion of the transaction, the chief executive officer owned 65,804 shares of the company’s stock, valued at $17,737,468.20. This represents a 27.53% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Bryan T. Durkin sold 4,200 shares of the firm’s stock in a transaction that occurred on Monday, February 23rd. The stock was sold at an average price of $309.65, for a total value of $1,300,530.00. Following the completion of the sale, the director owned 43,007 shares of the company’s stock, valued at $13,317,117.55. This represents a 8.90% decrease in their position. The SEC filing for this sale provides additional information. Over the last ninety days, insiders sold 30,248 shares of company stock valued at $8,355,450. Corporate insiders own 0.30% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts have recently weighed in on CME shares. JPMorgan Chase & Co. raised their price target on CME Group from $262.00 to $266.00 and gave the stock an “underweight” rating in a research note on Thursday, February 5th. Weiss Ratings restated a “buy (b+)” rating on shares of CME Group in a report on Monday, December 29th. Royal Bank Of Canada lifted their target price on shares of CME Group from $295.00 to $302.00 and gave the company a “sector perform” rating in a research note on Thursday, February 5th. Raymond James Financial decreased their target price on shares of CME Group from $311.00 to $310.00 and set an “outperform” rating for the company in a research report on Wednesday, February 4th. Finally, Deutsche Bank Aktiengesellschaft raised their price target on shares of CME Group from $312.00 to $316.00 and gave the company a “buy” rating in a report on Thursday, February 5th. Nine research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have issued a Sell rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Hold” and a consensus target price of $299.53.

CME Group Trading Up 1.0%

Shares of CME Group stock opened at $319.50 on Friday. CME Group Inc. has a 1 year low of $248.53 and a 1 year high of $322.57. The company’s fifty day simple moving average is $287.63 and its 200-day simple moving average is $275.97. The company has a market cap of $115.21 billion, a price-to-earnings ratio of 28.63, a PEG ratio of 3.74 and a beta of 0.27. The company has a current ratio of 1.03, a quick ratio of 1.02 and a debt-to-equity ratio of 0.12.

CME Group (NASDAQ:CME) last issued its quarterly earnings results on Wednesday, February 4th. The financial services provider reported $2.77 earnings per share for the quarter, beating analysts’ consensus estimates of $2.75 by $0.02. CME Group had a net margin of 62.45% and a return on equity of 14.65%. The firm had revenue of $1.65 billion during the quarter, compared to the consensus estimate of $1.64 billion. During the same period in the prior year, the firm earned $2.52 EPS. The business’s revenue was up 8.1% on a year-over-year basis. As a group, sell-side analysts expect that CME Group Inc. will post 10.49 EPS for the current year.

CME Group Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, March 26th. Investors of record on Tuesday, March 10th will be given a dividend of $1.30 per share. This represents a $5.20 dividend on an annualized basis and a yield of 1.6%. This is a boost from CME Group’s previous quarterly dividend of $1.25. The ex-dividend date of this dividend is Tuesday, March 10th. CME Group’s dividend payout ratio (DPR) is 44.80%.

More CME Group News

Here are the key news stories impacting CME Group this week:

• Positive Sentiment: CME reported record 2025 results: $6.5B in revenue, AD volume rose 6% to 28.1M contracts (commodities +12%, financials +5%), highlighting continued franchise growth and fee-related revenue strength. This earnings strength is the primary bullish catalyst. CME Group (CME) Achieves Record 2025 Results with $6.5B in Revenue
• Positive Sentiment: CME expanded physical-market infrastructure by approving the first aluminium warehousing facility in Taiwan, supporting commodities product growth and global market access for metals. That strengthens long-term fees and product diversification. CME approves first aluminium warehousing in Taiwan
• Neutral Sentiment: Intraday data and flow reports show mixed signals: QuiverQuant flagged heavy volume and both insider selling and sizable institutional position changes (some managers added, some trimmed). This suggests active rebalancing rather than a clear directional bet. $CME stock is up 2% today. Here’s what we see in our data.
• Neutral Sentiment: Reported short-interest data in the feed appears anomalous (zeros/NaN). No clear short-pressure signal is evident from that entry, so it shouldn’t be driving meaningful price moves. (Treat as data glitch/unreliable.)
• Negative Sentiment: CME experienced a brief technical glitch that halted metals and natural gas trading on Globex and briefly pressured the stock when markets reacted; trading was subsequently restarted. Operational reliability concerns can weigh on near-term sentiment until fully resolved. CME Group halts metals and natural gas trading on technical issues
• Negative Sentiment: Commentary criticizing CME’s Variable Storage Rate program (commodity storage economics) may pressure sentiment among some commodities market participants; impact is likely niche but could attract headlines. Why I Hate Variable Storage Rates

CME Group Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.